Skip to main content

Our progress on #FutureFresenius

  • We are progressing on our journey towards #FutureFresenius with a simplified structure, sharper focus and accelerated performance
  • We successfully completed the deconsolidation of Fresenius Medical Care - a landmark in the implementation of the #FutureFresenius program 
  • We place a clear focus on our Operating Companies Fresenius Kabi and Fresenius Helios: both have attractive market positions and excellent opportunities for profitable growth
  • We are actively managing our portfolio of assets where Fresenius lacks best ownership: our divestment program is well advancing
  • With our Fresenius Financial Framework, we set ambitious EBIT margin bands for our business segments
  • Fresenius Vamed’s transformation is progressing well with ongoing operational improvements
  • We significantly exceeded our Group cost saving target in 2023 by more than 40% and raised our 2025 structural productivity savings target 
     
Image Desc.

May 08, 2024
Bad Homburg, Germany

Conference Call Q1 2024, Fresenius

Live Webcast

Next event

“We took decisive actions in fiscal year 2023 and put Fresenius back on track. #FutureFresenius is driving improvements throughout the company and creating value. We added focus, simplified the structure, and delivered better financial performance. We will build on that momentum to further grow our businesses and accelerate earnings growth driven by the Operating Companies Fresenius Kabi and Fresenius Helios.

Michael Sen, Chairman of the Management Board

 

News

Share

Social Media

By clicking “I consent” you consent to the activation of the activity feed on this website and the following processing of your personal data related to it according to Section 2 of the Privacy Statement